Last reviewed: May 16, 2026
Last updated: May 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
9Amhealth's pricing model typically ranges from $99–$299 monthly depending on medication type, provider consultation tier, and delivery frequency. Total out-of-pocket costs often include initial medical assessment, optional lab work, and ongoing prescription refills. Understanding this structure helps patients compare value across telehealth GLP-1 providers.
GLP-1 therapy costs are significant, making informed provider selection crucial. Beyond price alone, patients benefit from understanding how their individual biomarkers and genetic predispositions may influence medication response, tolerability, and long-term cost-effectiveness. This precision-wellness approach can support more transparent conversations about total treatment investment.
How 9Amhealth Structures Monthly Program Fees
9Amhealth charges for initial medical consultations, typically $50–$100, plus monthly subscription or per-prescription dispensing fees. Medication costs are separate and depend on the specific GLP-1 formulation: semaglutide, tirzepatide, or other peptides. Some patients bundle consultations with medication refills; others pay à la carte.
Hidden costs can accumulate: lab work ($30–$150), pharmacy processing fees, shipping, and optional add-ons like nutrient panels or lifestyle coaching. Reviewing the full fee schedule before enrollment prevents billing surprises. Many telehealth platforms also charge cancellation fees if prescriptions are discontinued.
Comparing Total Medication and Service Costs Across GLP-1 Providers
GLP-1 pricing varies significantly across providers, influenced by medication source (branded vs. compounded), prescription strength, and service bundling. A detailed cost comparison framework helps patients evaluate not just monthly price but total value, including provider expertise, safety protocols, and personalization support offered with treatment.
| Cost Component |
9Amhealth Typical Range |
Compounded Alternatives |
Factors Affecting Price |
| Initial Consultation |
$50–$100 |
$0–$99 (varies by provider) |
Provider credentials, assessment depth, biomarker testing |
| Monthly Semaglutide |
$100–$200 |
$149 (PlexusDx range) |
Concentration, compounding source, pharmacy oversight |
| Monthly Tirzepatide |
$150–$250 |
$249 (PlexusDx range) |
Strength, formulation type, licensed 503A vs. 503B |
| Labs & Biomarkers |
$30–$150 |
$99–$298 (Precision Peptide Test) |
Genetic testing, metabolic panels, ongoing monitoring |
Why Biomarker Insights Can Influence Cost-Effectiveness
Patients who experience poor response or intolerance to their first GLP-1 often face costly dose adjustments, medication switches, and extended trial periods. Biomarker and genetic predisposition data gathered upfront may help providers make more informed initial selections, potentially reducing wasteful cycles and cumulative out-of-pocket spending.
The Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R pathways—markers that may provide context for peptide response patterns. While genetics do not guarantee exact medication success, this information can support more confident early conversations between patient and provider about which GLP-1 formulation aligns with individual physiology.
Safety, Provider Oversight, and Who Should Pursue This Treatment
GLP-1 therapy requires medical screening: kidney function, thyroid history, and blood glucose monitoring. Not all patients are appropriate candidates. Telehealth providers vary in screening rigor; some focus on rapid enrollment while others conduct thorough assessments. Ensure your chosen platform uses licensed 503A compounding pharmacies and maintains ongoing clinical oversight.
Patients with family history of thyroid cancer, severe kidney disease, or unstable diabetes should have extra scrutiny. Pregnant individuals and those planning pregnancy should avoid GLP-1 therapy. A qualified healthcare provider should interpret cost versus clinical benefit in your specific context, especially if personalization testing is pursued.
How PlexusDx Supports a More Personalized Approach
PlexusDx offers compounded semaglutide and tirzepatide from licensed 503A pharmacies at transparent monthly rates ($149/mo depending on formulation and concentration) with optional biomarker integration. This approach may help provide context for why certain GLP-1 pathways align better with individual genetic predispositions, supporting a more informed starting point rather than trial-and-error adjustments.
The Precision Peptide Genetic Test ($99 add-on or $298 standalone) reveals predispositions in GLP1R, GIPR, FTO, and MC4R gene variants. These markers may indicate differential response patterns to GLP-1 monotherapy versus dual-agonist protocols. This information should be interpreted with a qualified healthcare provider to inform which compounded formulation or dosing strategy may offer better early clinical alignment.
By combining transparent compounded-pharmacy pricing with genetic predisposition insights, patients can support more confident conversations with their provider about expected response, tolerability, and long-term cost-benefit. This precision-wellness model aims to reduce protocol changes and optimize treatment value over time.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is included in 9Amhealth's base monthly cost?
Base fees typically cover provider access and medication dispensing but exclude labs, consultation overages, and shipping. Always request the complete fee schedule before enrollment to avoid surprise charges.
How does compounded GLP-1 pricing compare to 9Amhealth?
PlexusDx compounded semaglutide ranges $149/mo and tirzepatide $249/mo. Exact costs vary by dosage and concentration. Compare total cost—medication plus consultations—across providers rather than medication price alone.
Can genetic testing reduce long-term GLP-1 costs?
Genetic predisposition data may support more informed initial medication selection, potentially reducing costly switches and dose adjustments. The Precision Peptide Test costs $99–$298 and should be discussed with your provider to assess clinical relevance.
Are compounded GLP-1 medications from PlexusDx FDA-approved?
Compounded medications from licensed 503A pharmacies are not FDA-approved but are legally dispensed under compounding regulations. Your provider should confirm the pharmacy's licensing and quality oversight before treatment starts.
Who should avoid GLP-1 therapy due to safety or eligibility concerns?
Individuals with personal or family thyroid cancer history, severe kidney disease, unstable diabetes, pregnancy, or planned pregnancy should avoid GLP-1s. A qualified provider must perform medical screening before initiation.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Curai Health Cost: Comparing GLP-1 Pricing Models and Clinical Value
Sesame Cost: Monthly Pricing, Subscription Tiers, and What's Included